Alaunos Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Alaunos Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q2 2024.
  • Alaunos Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 1.6M shares, a 99.3% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.6M -239M -99.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 16M -225M -93.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.6M -14.4M -90% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 241M +24.4M +11.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 241M +24.5M +11.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 241M +24.7M +11.4% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 16M -200M -92.6% Dec 31, 2022 10-K 2024-04-01
Q3 2022 216M +36.2K +0.02% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 216M +615K +0.29% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 216M +693K +0.32% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 216M +1.54M +0.72% Dec 31, 2021 10-K 2023-03-07
Q3 2021 216M +1.98M +0.93% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 216M +1.27M +0.59% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 215M +971K +0.45% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 215M +32.8M +18% Dec 31, 2020 10-K 2022-03-30
Q3 2020 214M +33.1M +18.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 214M +51.8M +31.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 214M +52M +32% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 182M +20.7M +12.9% Dec 31, 2019 10-K 2021-03-01
Q3 2019 181M +38.7M +27.1% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 162M +20.1M +14.1% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 162M +19.9M +14% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 161M +18.4M +12.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 142M +417K +0.29% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 142M +417K +0.29% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 142M +10M +7.57% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 143M +10.3M +7.77% Dec 31, 2017 10-K 2019-03-05
Q3 2017 142M +10.2M +7.77% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 142M +10.2M +7.77% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 132M +579K +0.44% Mar 31, 2017 10-Q 2017-05-01
Q4 2016 132M +658K +0.5% Dec 31, 2016 10-K 2018-03-01
Q3 2016 132M +845K +0.65% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 132M +910K +0.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 132M +3.57M +2.78% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 132M +27.3M +26.1% Dec 31, 2015 10-K 2017-02-16
Q3 2015 131M +28.2M +27.5% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 131M +30.1M +29.9% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 128M +27.6M +27.5% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 104M +4.29M +4.29% Dec 31, 2014 10-K 2016-02-24
Q3 2014 103M +19M +22.7% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 101M +17.2M +20.6% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 101M +16.9M +20.2% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 100M +16.9M +20.3% Dec 31, 2013 10-K 2015-02-26
Q3 2013 83.7M +4.06M +5.1% Sep 30, 2013 10-Q 2013-10-22
Q2 2013 83.5M +3.92M +4.92% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 83.7M +4.15M +5.22% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 83.2M +14M +20.3% Dec 31, 2012 10-K 2014-03-03
Q3 2012 79.6M +11.2M +16.3% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 79.6M +11.3M +16.6% Jun 30, 2012 10-Q/A 2012-08-28
Q1 2012 79.5M Mar 31, 2012 10-Q 2012-05-03
Q4 2011 69.2M +20.7M +42.8% Dec 31, 2011 10-K 2013-03-18
Q3 2011 68.5M +19.9M +41% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 68.3M Jun 30, 2011 10-Q/A 2011-08-09
Q4 2010 48.5M Dec 31, 2010 10-K 2012-02-29
Q3 2010 48.6M Sep 30, 2010 10-Q 2011-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.